MEDP
Medpace Holdings, Inc.
NasdaqGSUSDEQUITY
DELAYED
Last price
620.75
▲ 8.11 (1.32%)
MARKET · —
Price
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
612.64
Prev close
612.64
Day high
629.69
Day low
600.01
Volume
214.65K
Market cap
—
P/E (TTM)
—
52W range
373.00 – 677.90
Trailing performance
Returnvs SPY
1W
+7.30%
+8.7%
1M
+2.46%
-1.3%
3M
+44.33%
+41.2%
6M
+36.80%
+25.7%
YTD
+10.52%
-1.8%
1Y
+33.29%
+13.3%
3Y
+142.89%
+68.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on MEDP open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.53B | $2.11B | $1.89B | $1.46B | +20.0% |
| Operating revenue | $2.53B | $2.11B | $1.89B | $1.46B | +20.0% |
| Cost of revenue | $1.77B | $1.45B | $1.36B | $1.03B | +21.8% |
| Gross profit | $760.62M | $656.30M | $524.50M | $432.44M | +15.9% |
| Selling, general & admin | $197.56M | $180.18M | $161.35M | $131.40M | +9.6% |
| Total operating expense | $225.68M | $209.44M | $187.68M | $153.74M | +7.8% |
| Operating income | $534.93M | $446.87M | $336.82M | $278.70M | +19.7% |
| Net interest income | $12.78M | $25.00M | -$488.00K | -$2.90M | -48.9% |
| Pre-tax income | $542.38M | $475.92M | $335.68M | $282.86M | +14.0% |
| Tax provision | $91.25M | $71.54M | $52.87M | $37.49M | +27.6% |
| Net income | $451.12M | $404.39M | $282.81M | $245.37M | +11.6% |
| Net income to common | $451.12M | $404.34M | $282.62M | $245.21M | +11.6% |
| Basic EPS | 15.64 | 13.06 | 9.20 | 7.57 | +19.8% |
| Diluted EPS | 15.28 | 12.63 | 8.88 | 7.28 | +21.0% |
| EBIT | $534.93M | $446.87M | $336.82M | $278.70M | +19.7% |
| EBITDA | $563.06M | $476.12M | $363.15M | $301.04M | +18.3% |
| Basic shares | 28.85M | 30.96M | 30.72M | 32.39M | -6.8% |
| Diluted shares | 29.53M | 32.01M | 31.84M | 33.67M | -7.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $497.05M | $669.44M | $245.45M | $28.27M | -25.8% |
| Cash & short-term investments | $497.05M | $669.44M | $245.45M | $28.27M | -25.8% |
| Accounts receivable | $376.75M | $291.10M | $275.93M | $213.17M | +29.4% |
| Total current assets | $989.62M | $1.03B | $593.83M | $333.96M | -3.8% |
| Property, plant & equipment | $248.87M | $252.26M | $265.39M | $248.92M | -1.3% |
| Goodwill & intangibles | $695.82M | $696.76M | $698.21M | $700.40M | -0.1% |
| Total assets | $1.98B | $2.10B | $1.66B | $1.35B | -6.0% |
| Total current liabilities | $1.34B | $1.10B | $925.13M | $803.47M | +21.7% |
| Current debt | — | — | — | $50.00M | — |
| Total debt | $113.64M | $126.23M | $142.12M | $188.87M | -10.0% |
| Total liabilities | $1.52B | $1.28B | $1.10B | $966.11M | +18.9% |
| Retained earnings | -$459.98M | $8.17M | -$221.65M | -$359.83M | -5,732.2% |
| Shareholder equity | $459.07M | $825.54M | $558.95M | $386.39M | -44.4% |
| Working capital | -$354.12M | -$75.32M | -$331.30M | -$469.51M | -370.1% |
| Net tangible assets | -$236.75M | $128.78M | -$139.25M | -$314.02M | -283.8% |
| Shares issued | 28.44M | 30.70M | 30.82M | 31.16M | -7.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $451.12M | $404.39M | $282.81M | $245.37M | +11.6% |
| Depreciation & amortisation | $28.12M | $29.25M | $26.33M | $22.34M | -3.9% |
| Stock-based compensation | $34.79M | $25.51M | $20.52M | $21.41M | +36.3% |
| Change in working capital | $96.28M | $157.18M | $106.49M | $106.06M | -38.7% |
| Operating cash flow | $713.22M | $608.82M | $433.37M | $388.05M | +17.1% |
| Capital expenditure | -$31.36M | -$36.55M | -$36.65M | -$36.88M | +14.2% |
| Investing cash flow | -$31.14M | -$28.31M | -$34.63M | -$38.74M | -10.0% |
| Share buybacks | -$917.39M | -$169.87M | -$144.02M | -$847.85M | -440.1% |
| Financing cash flow | -$860.39M | -$154.01M | -$182.64M | -$775.77M | -458.7% |
| Free cash flow | $681.87M | $572.27M | $396.73M | $351.17M | +19.2% |
| End cash position | $497.05M | $669.44M | $245.45M | $28.27M | -25.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $707.33M | $706.60M | $708.45M | $659.90M | $603.31M | +0.1% |
| Operating revenue | $707.33M | $706.60M | $708.45M | $659.90M | $603.31M | +0.1% |
| Cost of revenue | $505.69M | $510.28M | $503.13M | $462.96M | $423.30M | -0.9% |
| Gross profit | $201.64M | $196.33M | $205.32M | $196.94M | $180.01M | +2.7% |
| Selling, general & admin | $48.10M | $47.92M | $44.92M | $48.08M | $46.66M | +0.4% |
| Total operating expense | $54.81M | $54.82M | $52.05M | $55.13M | $53.68M | -0.0% |
| Operating income | $146.82M | $141.50M | $153.27M | $141.81M | $126.33M | +3.8% |
| Net interest income | $4.99M | $5.12M | $3.72M | $1.52M | $1.08M | -2.6% |
| Pre-tax income | $151.66M | $147.59M | $156.83M | $142.84M | $124.54M | +2.8% |
| Tax provision | $30.30M | $23.72M | $21.70M | $31.70M | $34.28M | +27.7% |
| Net income | $121.36M | $123.87M | $135.13M | $111.14M | $90.26M | -2.0% |
| Net income to common | $121.36M | $123.87M | $135.13M | $111.14M | $90.26M | -2.0% |
| Basic EPS | 4.31 | 4.35 | 4.78 | 3.95 | 3.16 | -0.9% |
| Diluted EPS | 4.25 | 4.28 | 4.67 | 3.86 | 3.10 | -0.7% |
| EBIT | $146.82M | $141.50M | $153.27M | $141.81M | $126.33M | +3.8% |
| EBITDA | $153.53M | $148.41M | $160.40M | $148.86M | $133.35M | +3.5% |
| Basic shares | 28.17M | 28.45M | 28.29M | 28.14M | 28.60M | -1.0% |
| Diluted shares | 28.55M | 28.96M | 28.96M | 28.82M | 29.14M | -1.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $502.69M | $652.68M | $497.05M | $285.35M | $46.33M | -23.0% |
| Cash & short-term investments | $502.69M | $652.68M | $497.05M | $285.35M | $46.33M | -23.0% |
| Accounts receivable | $420.56M | $370.41M | $376.75M | $362.32M | $371.92M | +13.5% |
| Total current assets | $1.05B | $1.14B | $989.62M | $737.28M | $520.80M | -7.8% |
| Property, plant & equipment | $282.96M | $263.36M | $248.87M | $256.76M | $264.99M | +7.4% |
| Goodwill & intangibles | $695.51M | $695.66M | $695.82M | $696.05M | $696.29M | -0.0% |
| Total assets | $2.06B | $2.13B | $1.98B | $1.75B | $1.57B | -3.4% |
| Total current liabilities | $1.44B | $1.35B | $1.34B | $1.28B | $1.22B | +6.7% |
| Total debt | $120.10M | $122.26M | $113.64M | $119.07M | $124.95M | -1.8% |
| Total liabilities | $1.62B | $1.53B | $1.52B | $1.46B | $1.40B | +6.0% |
| Retained earnings | -$511.37M | -$336.11M | -$459.98M | -$596.24M | -$703.22M | -52.1% |
| Shareholder equity | $433.86M | $598.31M | $459.07M | $293.64M | $172.35M | -27.5% |
| Working capital | -$385.14M | -$205.96M | -$354.12M | -$546.63M | -$699.64M | -87.0% |
| Net tangible assets | -$261.64M | -$97.35M | -$236.75M | -$402.41M | -$523.94M | -168.8% |
| Shares issued | 27.91M | 28.63M | 28.44M | 28.24M | 28.16M | -2.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $121.36M | $123.87M | $135.13M | $111.14M | $90.26M | -2.0% |
| Depreciation & amortisation | $6.71M | $6.91M | $7.13M | $7.05M | $7.01M | -2.8% |
| Stock-based compensation | $4.35M | $4.92M | $5.62M | $6.32M | $5.95M | -11.6% |
| Change in working capital | $19.40M | -$8.70M | $22.12M | $87.46M | $5.59M | +323.1% |
| Operating cash flow | $162.01M | $151.79M | $192.65M | $246.21M | $148.53M | +6.7% |
| Capital expenditure | -$23.91M | -$6.81M | -$4.54M | -$10.71M | -$6.11M | -250.9% |
| Investing cash flow | -$23.89M | -$6.75M | -$4.47M | -$10.66M | -$6.02M | -254.0% |
| Share buybacks | -$294.76M | $0 | $0 | -$4.57M | -$540.91M | — |
| Financing cash flow | -$288.34M | $12.67M | $22.73M | $3.41M | -$540.56M | -2,375.8% |
| Free cash flow | $138.10M | $144.97M | $188.12M | $235.50M | $142.41M | -4.7% |
| End cash position | $502.69M | $652.68M | $497.05M | $285.35M | $46.33M | -23.0% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
599.44
+3.55% from price
SMA 20
590.35
+5.15% from price
SMA 50
548.67
+13.14% from price
SMA 100
501.85
+23.69% from price
SMA 200
520.37
+19.29% from price
EMA 12
597.95
+3.81% from price
EMA 26
580.87
+6.87% from price
EMA 50
554.34
+11.98% from price
RSI (14)
66.4
Neutral
MACD (12,26,9)
17.08
Hist 0.12
ATR (14)
17.62
2.84% of price
Realised vol 30D
46.5%
Annualised
Bollinger upper
617.57
20, 2σ
Bollinger lower
563.13
20, 2σ
50 / 200 cross
Golden
548.67 vs 520.37
Trend bias
Above 200
+19.29%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.76
Less volatile than market
Correlation to SPY
0.22
Largely independent
Realised vol 30D
46.5%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-36.6%
Peak to trough
Max drawdown 5Y
-42.9%
Peak to trough
ATR 14
17.62
2.84% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Medpace Holdings Insider Sold Shares Worth $4,414,590, According to a Recent SEC Filing
MT Newswires · 1d ago
Medpace Holdings Insider Sold Shares Worth $3,043,150, According to a Recent SEC Filing
MT Newswires · 1d ago
Medpace Holdings Insider Sold Shares Worth $26,281,390, According to a Recent SEC Filing
MT Newswires · 1d ago
Why Is Medpace (MEDP) Up 1.1% Since Last Earnings Report?
Zacks · 2d ago
Medpace (MEDP) is an Incredible Growth Stock: 3 Reasons Why
Zacks · 4d ago
Medpace (MEDP) Stock May Be 9% Undervalued As Growth Expectations Hold
Simply Wall St. · 5d ago
Will Medpace’s (MEDP) Revenue Beat and Guidance Hike Change Medpace Holdings' (MEDP) Narrative
Simply Wall St. · 5d ago
Medpace Holdings (MEDP) Following Its Q2 Beat And Guidance Raise Looks Fully Valued
Simply Wall St. · 6d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.